AKE 0.00% $9.83 allkem limited

The announcements relating to the JV have been ambiguous on the...

  1. niu
    1,638 Posts.
    lightbulb Created with Sketch. 578
    The announcements relating to the JV have been ambiguous on the equity contribution. I initially read it as a buy in to the JV prior to equity contribution but it can be read either way. If the buy-in price covers their capital contribution then TT face no development cost risk which might seem a little inequitable but on the other hand it would also suggest the NPV has been overstated and they have overpaid.

    I am confortable with the deal whichever way the fine print has been worded. There should be change left over following TTs buy-in.
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.